Wall Street Prep – Biotech Sum of the Parts Valuation

    Awaiting product image

    $39.00

    You are currently accessing the institutional-grade blueprint for <b>Wall Street Prep – Biotech Sum of the Parts Valuation</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.

    Description

    Wall Street Prep – Biotech Sum of the Parts Valuation

    Wall Street Prep - Biotech Sum of the Parts Valuation

    Ideal for investment banking private equity and VC professionals focusing on the biotechnology industry, you will learn how to build a biotech-sum-of-the-parts valuation the way it’s done on the job.

    Real World “On the Job” Biotech SOTP Valuation

    What You Will Learn

    • Market size and model potential revenue for a therapeutic asset in clinical development
    • Road-map the path to commercialization for a biotech through the FDA approval process
    • Apply the appropriate “probability of success”” to a clinical-stage pre-revenue biotech company
    • Apply key assumptions and tie together a long-range forecast of multiple products with a DCF analysis

    Want to value a clinical-stage, pre-revenue biotech? An ordinary discounted cash flow analysis won’t cut it. Instead, you need to build a long-range sum-of-the-parts valuation.

    This 60-minute video short course + model template bridges the gap between academics and the real world and equips trainees with the practical modeling skill set needed to build a biotech SOTP Valuation.

    This course assumes no prior knowledge in biotech company valuation.

    Who is This Program For?

    This biotech sum-of-the-parts valuation course is designed for professionals and those pursuing a career in the following finance careers:

    • Investment Banking
    • Venture Capital
    • Private Equity
    • Anyone who wants to learn how professionals build a biotech-sum-of-the-parts valuation

    Course TOC

    Biotech Sum of the Parts Valuation

    1. Biotech SOTP welcome
    2. Biotech SOTP introduction
    3. Course Downloads
    4. Overview of a sum of the parts valuation
    5. Major building blocks for a biotech SOTP
    6. Model assumptions dashboard
    7. Biotech company lifecycle
    8. Identify peak revenue opportunity
    9. Therapeutic areas overview
    10. Product launch timing and uptake curve
    11. Patent life and loss of exclusivity
    12. Road to commercialization
    13. FDA clinical trials
    14. Building a commercial infrastructure
    15. Completing the SOTP
    16. Probability of success
    17. Build out one part of the SOTP (Product #1)
    18. Finalizing the valuation model
    19. Valuation sensitivities
    20. Example: Blueprint Medicines Corp
    21. Biotech SOTP Course Review

    Prerequisites

    This course does not assume a prior background in Biotech or Healthcare. However, those who enroll should have an introductory knowledge of accounting (e.g. interaction of balance sheet, cash flow, and income statement) and proficiency in Excel. Students with no prior background in Accounting should enroll in the Accounting Crash Course. Students with limited experience using Excel should enroll in the Excel Crash Course.

    Get Digital Download ” Wall Street Prep – Biotech Sum of the Parts Valuation ” Right Now!

    Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>

    Placeholder
    Wall Street Prep – Biotech Sum of the Parts Valuation